![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 29, 20137-20148, July 18, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(C/EBP
) Transcriptional Activity by Sequestering C/EBP
to the Nuclear Periphery*From the Ohio State Biochemistry Program, Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210
CCAAT/enhancer binding protein
(C/EBP
) plays a key role in mammary epithelial cell G0 growth arrest, and "loss of function" alterations in C/EBP
have been reported in breast cancer and acute myeloid leukemia. C/EBP
is regulated at the transcriptional, post-transcriptional, and post-translational levels, suggesting tight control of C/EBP
content and function. Protein inhibitors of activated STATs (PIASs) regulate a growing number of transcription factors, including C/EBPs. HC11 nontransformed mammary epithelial cells express PIAS3, PIASxβ, and PIASy, and all three PIAS family members repress C/EBP
transcriptional activity. PIASy is the most potent, however, repressing C/EBP
transcriptional activity by >80%. PIASy repression of C/EBP
transcriptional activity is dependent upon interaction between the highly conserved PIASy N-terminal nuclear matrix binding domain (SAPD) and the C/EBP
transactivation domain (TAD). PIASy repression of C/EBP
transcriptional activity is independent of histone deacetylase activity, PIASy E3 SUMO ligase activity, and C/EBP
sumoylation status. PIASy expression is associated with C/EBP
translocation from nuclear foci, where C/EBP
co-localizes with p300, to the nuclear periphery. PIASy-mediated translocation of C/EBP
is dependent upon the PIASy SAPD and C/EBP
TAD. PIASy reduces the expression of C/EBP
adhesion-related target genes and enhances repopulation of open areas within a cell monolayer in the in vitro "scratch" assay. These results demonstrate that PIASy represses C/EBP
by a mechanism that requires interaction between the PIASy SAPD and C/EBP
TAD and does not require PIASy SUMO ligase activity or C/EBP
sumoylation. PIASy alters C/EBP
nuclear localization, reduces C/EBP
transcriptional activity, and enhances cell proliferation/migration.
Received for publication, February 19, 2008 , and in revised form, May 1, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grants CA57607-14 (to J. D.) and P30 CA16058 (to The Ohio State University). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both of these authors contributed equally to this work.
2 To whom correspondence should be addressed: Dept. of Veterinary Biosciences, 1925 Coffey Rd., Columbus, OH 43210-1093. Tel.: 614-292-4261; Fax: 614-292-6473; E-mail: dewille.1{at}osu.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |